NCT04231422 is a clinical trial of Platelet-rich plasma in Penile Elongation, sponsored by Judson Brandeis.

Who is sponsoring NCT04231422?

NCT04231422 is sponsored by Judson Brandeis.

What drugs are being tested in NCT04231422?

Interventions in NCT04231422: Platelet-rich plasma.

What condition does NCT04231422 study?

NCT04231422 studies Penile Elongation.

Is NCT04231422 still recruiting?

NCT04231422 is currently status unknown. Last updated 18 January 2020.

Last reviewed 2020-01-18 · How we verify

NCT04231422

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Proof of Concept Top Evaluate a Novel Penile Lengthening Protocol

Status unknown Last updated 18 January 2020

What this trial tests

trial testing Platelet-rich plasma in Penile Elongation in 30 participants. Status unknown.

Timeline

12 November 2019

Primary endpoint
12 May 2021

12 July 2021

Quick facts

Lead sponsor	Judson Brandeis
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	12 November 2019
Primary completion	12 May 2021
Estimated completion	12 July 2021
Sites	1 location across United States

Drugs / interventions tested

Platelet-rich plasma

Conditions studied

Penile Elongation — all drugs for Penile Elongation →

Sponsor

Judson Brandeis

Who can join

Adults 20 to 55, male only, with Penile Elongation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to examine and quantify the efficacy and safety of a new treatment protocol using platelet-rich plasma for penile length enhancement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Platelet-rich plasma

Trials testing the same drug.

NCT07103551 — Evaluation of the Efficacy of Injectable Platelet-rich Plasma in Tooth Movement Acceleration With Clear Aligner · Phase 3 · not yet recruiting
NCT06372600 — Effect of Extracorporeal Shock Wave Combined With Autologous Platelet-rich Plasma Injection on Rotator Cuff Calcific Ten · NA · not yet recruiting
NCT06442319 — The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction. · NA · recruiting
NCT05329116 — Efficacy of Mesotherapy Added to Intra-articular Platelet-rich Plasma (PRP) in Patients With Knee Osteoarthritis · NA · unknown
NCT05214924 — Effectiveness of iPRF Injections in Temporomandibular Joints Degeneration Management · Phase 2, PHASE3 · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04231422 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Judson Brandeis
Last refreshed: 18 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04231422.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing